Skip to main content

Table 2 Clinical and laboratory characteristics of the juvenile rheumatoid arthritis (JRA) patients characterised

From: Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis

Sample

Clinical features and rheumatoid factor status

Age

Onset

Age

History

Fibrinogen ICs (O.D.)

Anti-cit. fibrinogen IgG (O.D.)

anti-CCPa

(IU/mL)

RFb

(IU/mL)

JRA 1

Polyarthritis, RF-

2

2

0.18

0.11

21.3

11.7

JRA 4

Polyarthritis, RF+

13

 

0.77

1.25

841.1

127.6

JRA 8

Polyarthritis, RF+

3

16

0.53

0.43

483.2

262.6

JRA 13

Polyarthritis, RF+

13

13

0.54

1.45

255.4

274.7

JRA 17

Systemic arthritis

  

0.15

0.10

24.8

24.9

JRA 22

Polyarthritis, RF-

15

15

0.13

0.09

22.7

27.1

JRA 27

Polyarthritis, RF-

1

2

0.10

0.08

20.3

7.6

JRA 31

Persistent oligoarthritis

  

0.16

0.13

21.5

7.3

JRA 32

Polyarthritis, RF-

5

5

0.12

0.37

26.7

6.3

JRA 41

Enthesitis-related arthritis

13

14

0.14

0.08

20.8

13.1

JRA 42

Systemic arthritis

12

12

0.17

0.08

21.8

7.1

JRA 44

Polyarthritis, RF-

9

9

0.19

0.09

20.9

10.1

JRA 49

Polyarthritis, RF+

9

 

1.72

0.74

1275.4

295.2

JRA 51

Systemic arthritis

5

5

0.14

0.09

21.4

7.6

JRA 71

Polyarthritis, RF+

 

10

0.19

0.21

360.9

186.1

JRA 79

Polyarthritis, RF-

4

4

0.20

0.10

22.1

11.7

JRA 88

Polyarthritis, RF+

11

11

0.51

0.35

287.0

236.4

JRA 106

Extended oligoarthrits

1

3

0.15

0.12

22.0

10.0

JRA 110

Persistent oligoarthritis

  

0.15

0.10

24.9

14.6

JRA 112

Enthesitis related arthritis

  

0.14

0.12

22.5

15.9

  1. a,bMeasured with commercial kits. JRA, juvenile rheumatoid arthritis; IC, immune complex; CCP, cyclic-citrullinated peptides; RF, rheumatoid factor; O.D., optical density